Literature DB >> 9419047

Performance of the Amyotrophic Lateral Sclerosis Functional Rating Scale (ALSFRS) in multicenter clinical trials.

J M Cedarbaum1, N Stambler.   

Abstract

The Amyotrophic Lateral Sclerosis Functional Rating Scale (ALSFRS) is a 10-item functional inventory which was devised for use in therapeutic trials in ALS. Each item is rated on a 0-4 scale by the patient and/or caregiver, yielding a maximum score of 40 points. The ALSFRS assesses patients' levels of self-sufficiency in areas of feeding, grooming, ambulation and communication. Rotated factor analysis of the ALSFRS found that the rating items group logically and consistently into four categories. The ALSFRS has been validated both cross-sectionally and longitudinally against muscle strength testing, the Schwab and England ADL rating scale, the Clinical Global Impression of Change (CGIC) scale, and independent assessments of patient's functional status. In this report, we use the data provided by the placebo patients who participated in the ALS CNTF Treatment Study (ACTS) to demonstrate the robustness, test-retest reliability and consistency of the ALSFRS as employed in a large, multicenter clinical trial.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9419047     DOI: 10.1016/s0022-510x(97)00237-2

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  59 in total

1.  Crowdsourced analysis of clinical trial data to predict amyotrophic lateral sclerosis progression.

Authors:  Robert Küffner; Neta Zach; Raquel Norel; Johann Hawe; David Schoenfeld; Liuxia Wang; Guang Li; Lilly Fang; Lester Mackey; Orla Hardiman; Merit Cudkowicz; Alexander Sherman; Gokhan Ertaylan; Moritz Grosse-Wentrup; Torsten Hothorn; Jules van Ligtenberg; Jakob H Macke; Timm Meyer; Bernhard Schölkopf; Linh Tran; Rubio Vaughan; Gustavo Stolovitzky; Melanie L Leitner
Journal:  Nat Biotechnol       Date:  2014-11-02       Impact factor: 54.908

2.  A modified Hammersmith functional motor scale for use in multi-center research on spinal muscular atrophy.

Authors:  Kristin J Krosschell; Jo Anne Maczulski; Thomas O Crawford; Charles Scott; Kathryn J Swoboda
Journal:  Neuromuscul Disord       Date:  2006-06-05       Impact factor: 4.296

Review 3.  Advances in clinical trials for amyotrophic lateral sclerosis.

Authors:  Paul H Gordon
Journal:  Curr Neurol Neurosci Rep       Date:  2005-02       Impact factor: 5.081

4.  Assessment of swallowing by oropharyngoesophageal scintigraphy in patients with amyotrophic lateral sclerosis.

Authors:  Bruno Fattori; Mariano Grosso; Paolo Bongioanni; Andrea Nacci; Renza Cristofani; Abedallatif AlSharif; Rosaria Licitra; Fabio Matteucci; Bruno Rossi; Domenico Rubello; Francesco Ursino; Giuliano Mariani
Journal:  Dysphagia       Date:  2006-10       Impact factor: 3.438

5.  Model-Based and Model-Free Techniques for Amyotrophic Lateral Sclerosis Diagnostic Prediction and Patient Clustering.

Authors:  Ming Tang; Chao Gao; Stephen A Goutman; Alexandr Kalinin; Bhramar Mukherjee; Yuanfang Guan; Ivo D Dinov
Journal:  Neuroinformatics       Date:  2019-07

6.  Trail Making Test error analysis in classic motor neuron disease.

Authors:  Foteini Christidi; Evangelia Kararizou; Nikolaos I Triantafyllou; George P Paraskevas; Ioannis Zalonis
Journal:  Neurol Sci       Date:  2012-11-18       Impact factor: 3.307

Review 7.  Clinical Measures of Disease Progression in Amyotrophic Lateral Sclerosis.

Authors:  Seward B Rutkove
Journal:  Neurotherapeutics       Date:  2015-04       Impact factor: 7.620

8.  Impairment of GH secretion in amyotrophic lateral sclerosis is not affected by riluzole treatment.

Authors:  L L Morselli; P Bongioanni; M Genovesi; R Licitra; B Rossi; L Murri; F Bogazzi; E Cecconi; E Martino; M Gasperi
Journal:  J Endocrinol Invest       Date:  2007-10       Impact factor: 4.256

9.  The influence of psychological state and motivation on brain-computer interface performance in patients with amyotrophic lateral sclerosis - a longitudinal study.

Authors:  Femke Nijboer; Niels Birbaumer; Andrea Kübler
Journal:  Front Neurosci       Date:  2010-07-21       Impact factor: 4.677

10.  Early treatment with noninvasive positive pressure ventilation prolongs survival in Amyotrophic Lateral Sclerosis patients with nocturnal respiratory insufficiency.

Authors:  Pierluigi Carratù; Lucia Spicuzza; Anna Cassano; Mauro Maniscalco; Felice Gadaleta; Donato Lacedonia; Cristina Scoditti; Ester Boniello; Giuseppe Di Maria; Onofrio Resta
Journal:  Orphanet J Rare Dis       Date:  2009-03-10       Impact factor: 4.123

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.